SATURN: Hormonal Therapy, SBRT May Lower PSA Rates in mHSPC | GU Oncology Now
The SATURN trial examined the addition of dual ARPIs and metastasis-directed SBRT to intermittent ADT to determine if the combination can improve recurrence rates over ADT alone.